Iliparcil

CAS No. 137214-72-3

Iliparcil( —— )

Catalog No. M36128 CAS No. 137214-72-3

Iliparcil is an antithrombotic compound with oral activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 307 In Stock
10MG 444 In Stock
25MG 673 In Stock
50MG 918 In Stock
100MG 1256 In Stock
200MG 1702 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Iliparcil
  • Note
    Research use only, not for human use.
  • Brief Description
    Iliparcil is an antithrombotic compound with oral activity.
  • Description
    Iliparcil is an antithrombotic compound with oral activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    137214-72-3
  • Formula Weight
    338.38
  • Molecular Formula
    C16H18O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C)C=1C=2C(=CC(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)CS3)=CC2)OC(=O)C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Risuteganib hydrochl...

    Risuteganib hydrochloride is an anti-integrin that downregulates oxidative stress and restores homeostasis, and targets three integrin receptors that are implicated in dry age-related macular degeneration (AMD) in order to restore homeostasis in the retina.

  • 3,5-Di-O-caffeoylqui...

    3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.

  • GSK3368715 dihydroch...

    GSK3368715 dihydrochloride (EPZ019997 dihydrochloride) is an orally active and potent inhibitor of type I protein arginine methyltransferases (PRMTs), including PRMT1, PRMT3, PRMT4, PRMT6, and PRMT8.